An interventional study of Caregiver-Assisted Pain Coping Skills Training (CG-PCST) in Pain, Dementia, Mild and Dementia, Moderate, sponsored by Duke University. Completed at 1 site in United States. Open to participants aged 50 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by Duke University · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 51 studies in Pain by Duke University — 8 open to participants now, 8 under way, none of them phase 3. Pain · Duke University.
Among the 51 studies in Pain by Duke University, this one is the 22nd largest by enrollment of the 46 interventional ones that give a count, is one of 4 that started in 2025, is one of 29 with no phase, and was the 49th registered.
10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.
Browse Pain studies →8 of the 51 studies in Pain by Duke University are open now, in 2 countries. Recruiting first, the newest first:
Duke University · Sites in United States
Ages 6 mo–4 yrs
Duke University · Sites in United States
Ages 18–90
Duke University · Sites in United States
Ages 18+
Duke University · Sites in United States
Ages 18–90 · Healthy volunteers
Duke University · Sites in United States
Ages 18+ · Women only · Healthy volunteers
By country, each count listing its studies:
Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.
This study: 50 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
51 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 4 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 65 is close to the median of 66 across 8,512 interventional studies indexed under Pain.
Median enrollment 64 across the 46 interventional studies, 38 across the 5 observational. Of the 40 that completed or were terminated, 19 (48%) have results posted.
This tab as a report to print or save as PDF → With an account.
Duke University is the lead sponsor of 2,064 studies on the registry; 271 are open to participants now.
Of its 204 completed or terminated interventional studies of FDA-regulated products, 170 (83%) have results posted.
7 of the studies in Pain by Duke University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04278404Duke UniversityPharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) | 2026-11 |
| NCT07525063Duke UniversityPain & Reward Neuromodulation of CNS Circuits | 2026-12 |
| NCT06636721Duke UniversityLung Cancer and Aging: Improving Well-being for Older Adults With Lung Cancer | 2027-05-01 |
| NCT05669027Duke UniversityMobile Neurofeedback for Low Back Pain | 2027-05-01 |
| NCT06962306Duke UniversityOptimizing Perioperative Analgesia to Lower Pain Following Cleft Palate Surgery | 2027-06-04 |
Add all 7 to your calendar (.ics) → With an account.
Among the 51 studies in Pain by Duke University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of the study is to develop a caregiver-assisted pain coping skills training program for older adults who have pain and mild to moderate dementia and are living at home with a family caregiver. The investigators are planning to recruit 30 patient-caregiver dyads (60 individuals).
Involving caregivers in a pain coping skills protocol is likely to optimize treatment outcomes in several ways.
First, people with dementia (PWD) are likely to have difficulty learning and remembering pain coping skills; training the caregiver to coach the patient in the use of the skills is likely to improve the patients' acquisition and ongoing use of learned skills.
Second, caregiver involvement in pain coping skills training may increase their understanding of how to gauge how much pain the PWD is experiencing and the impact of pain management strategies. This understanding is increasingly important as the patient's disease progresses, and s/he is less able to report pain verbally.
Third, caregiver-assisted pain management training may enhance caregivers' self-confidence for managing the patient's pain.
Finally, by participating in the pain coping skills training protocol, caregivers may learn coping skills (such as relaxation) that can help them manage the stress associated with caring for a PWD and pain which can be significant.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Patients:
Caregivers:
Exclusion Criteria:
Patient and caregivers
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patient and caregiver dyads will receive five 45-60 minute sessions over 6-8 week period. This will be over videoconference with a masters-level therapist. All sessions will be audio recorded.
Behavioral: Caregiver-Assisted Pain Coping Skills Training (CG-PCST)
Patient-caregiver dyads will receive five, forty-to-sixty-minute sessions over a six-to-eight-week period with a therapist to learn pain coping skills. These include training caregivers in strategies for assessing patient pain, including nonverbal pain behaviors (e.g., grimacing, bodily tension, labored breathing), which will become increasingly important as the patient's ability to express pain verbally decreases. The therapist will also train the caregiver to coach the patient in the use of the skills during activities that are challenging because of pain. We will focus on increasing positive patient-caregiver interactions and patient engagement in valued activities. Throughout the training, the therapist will help the patient and caregiver learn strategies for fostering regular home practice and application of the skills, identify challenges in using the skills, and find strategies for coping with challenges.
Client Satisfaction Questionnaire
Caregiver completes. Score range: 1-4; higher score indicates better outcome
Time frame: Post-intervention (approximately 8 weeks)
Quality of life in Alzheimer's Disease Caregiver version and Patient version
Patient and Caregiver will complete Patient QOL. Score range: 13-52; higher score indicates better outcome
Time frame: Baseline and post-intervention (approximately 8 weeks)
Brief Pain Inventory-Interference Items
Patient and Caregiver will complete Patient pain interference. Score range: 0-10; higher score indicates worse outcome
Time frame: Baseline and post-intervention (approximately 8 weeks)
Caregiver Self-Efficacy in Pain Management
Caregiver will complete caregiver self-efficacy. Score range: 0-10; higher score indicates better outcome
Time frame: Baseline and post-intervention (approximately 8 weeks)
Numeric pain scale & verbal descriptor
Patient will complete patient pain intensity. Score range: 0-19; higher score indicates worse outcome
Time frame: Baseline and post-intervention (approximately 8 weeks)
Checklist of nonverbal pain indicators
Caregiver will complete patient pain intensity. Score range: 0-10; higher score indicates worse outcome
Time frame: Baseline and post-intervention (approximately 8 weeks)
Zarit burden interview
Caregivers will complete caregiver burden. Score range: 0-88; higher score indicates worse outcome
Time frame: Baseline and post-intervention (approximately 8 weeks)
Caregiver appraisal-satisfaction scale
Caregiver will complete caregiver satisfaction. Score range: 0-10; higher score indicates worse outcome
Time frame: Baseline and post-intervention (approximately 8 weeks)
Neuropsychiatric inventory
Caregiver will complete patient neuropsychiatry behaviors. Score range: 0-144; higher score indicates worse outcome
Time frame: Baseline and post-intervention (approximately 8 weeks)
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Ran from Aug 2025 to primary completion in Sep 2026, 13 months.
Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's 13 months is above that.
Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 18, 2026: primary completion Dec 2026 → Sep 2026 and completion Dec 2026 → Sep 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.